University announces partnership with AVROBIO for Hunter syndrome gene therapy

Press/Media: Research

Description

The University of Manchester has announced today a groundbreaking gene therapy partnership to ease the lifelong suffering of people with Hunter syndrome.

The University has agreed to a worldwide license and collaborative research funding agreement with AVROBIO Inc., a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, based in Cambridge, Massachusetts, USA.

Period5 Oct 2020

Media coverage

1

Media coverage

  • TitleUniversity announces partnership with AVROBIO for Hunter syndrome gene therapy
    Media name/outletThe University of Manchester
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date5/10/20
    DescriptionThe University of Manchester has announced today a ground-breaking gene therapy partnership to ease the lifelong suffering of people with Hunter syndrome.

    The University has agreed to a worldwide license and collaborative research funding agreement with AVROBIO, Inc., a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, based in Cambridge, Massachusetts, USA.
    URLhttps://www.manchester.ac.uk/discover/news/university--announces-partnership-with-avrobio-for-hunter-syndrome-gene-therapy?
    PersonsBrian Bigger, Simon Jones, Robert Wynn
View all 1
View less